# UNH — slm-full-cpu

## Metadata

ticker: UNH
arm: slm-full-cpu
judge_prompt_version: v2
context_sha256: 8e39aa5267cfa504828316d458929816cfb6be6ebed52331aed13b88d3d426d7
slm_endpoint: slm-cpu
slm_url: http://llamacpp.financial-agent.svc:8080
slm_served_name: qwen3.6-35b-a3b-q4km
slm_artifact: ggml-org/Qwen3.6-35B-A3B-GGUF@baec3ebee244827cda0f4557eafa8b28f7545fa6:Qwen3.6-35B-A3B-Q4_K_M.gguf sha256:671e47e0ec53c665d048b98c3ecbfd5236b5ca9c3e02ed19fc8f81f7b85140c7
slm_build: b11347-5fc4f3c8c
slm_model_path: /models/Qwen3.6-35B-A3B-Q4_K_M.gguf
slm_model_ftype: Q4_K - Medium
slm_total_slots: 4
slm_n_ctx: 32768
slm_n_params: 34660610688
slm_model_size_bytes: 20408576512
slm_thinking: off
slm_sampling: {"planner": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "rag": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 2048, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "react": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "section": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 768, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "synthesis": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 4096, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.2, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}}
llm_calls: 7
llm_endpoints: slm-cpu
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 665, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 169.004, "latency_s_total": 169.004, "parse_failure": 0, "prompt_tokens": 3060, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 366, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 136.702, "latency_s_total": 136.702, "parse_failure": 0, "prompt_tokens": 3049, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 149, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 40.247, "latency_s_total": 40.247, "parse_failure": 0, "prompt_tokens": 841, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 150, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 42.497, "latency_s_total": 42.497, "parse_failure": 0, "prompt_tokens": 835, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 159, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 48.293, "latency_s_total": 48.293, "parse_failure": 0, "prompt_tokens": 437, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 151, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 75.606, "latency_s_total": 75.606, "parse_failure": 0, "prompt_tokens": 744, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 888, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 145.284, "latency_s_total": 145.284, "parse_failure": 0, "prompt_tokens": 1594, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 378.58,
  "currency": "USD",
  "market_cap": 339811434496.0,
  "pe_ratio": 24.34598,
  "forward_pe": 16.743778,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "financial_currency": "USD",
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin_pct": 3.14,
  "dividend_yield": 2.45,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] Based on the provided text from the Annual Report on Form 10-K for UNH, the key takeaways regarding risk factors and business operations include:

**Forward-Looking Statements and General Risks**
The report contains forward-looking statements protected by the Private Securities Litigation Reform Act of 1995. These statements involve significant risks and uncertainties that may cause actual results to differ materially from expectations. The company does not undertake an obligation to update these statements to reflect events occurring after the report date.

**Medical Cost Management and Profitability**
*   **Risk-Based Products:** Nearly 80% of total consolidated revenues come from risk-based products where the company assumes the risk for medical and administrative costs in exchange for premiums.
*   **Estimation Challenges:** Profitability depends heavily on the ability to accurately predict, price, and manage medical costs. Estimates involve extensive judgment and variability; even small differences between predicted and actual costs can significantly impact financial results.
*   **Cost Drivers:** Actual costs may exceed estimates due to medical inflation, increased service utilization, provider billing intensity, new or costly drugs and technologies, pandemics, climate change effects, and regulatory changes.
*   **Fixed Premiums:** Cost increases exceeding forecasts generally cannot be recovered through higher premiums during the fixed contract period.
*   **Value-Based Care:** For Optum Health’s fully accountable value-based arrangements, failure to deliver higher-quality outcomes at lower costs or to integrate care delivery models could adversely affect financial positions.

**Technology, Data Integrity, and Cybersecurity**
*   **System Integration:** Failure to protect, consolidate, and integrate information systems successfully could result in higher-than-expected costs. Software products may contain design defects or encounter installation complications.
*   **Data Integrity:** The business relies on the integrity, timeliness, and accuracy of data. Inaccurate, incomplete, or outdated data can lead to product failures, loss of customers, pricing errors, fraud issues, regulatory sanctions, and increased operating expenses.
*   **Cybersecurity Threats:** The company is regularly targeted by cyberattacks and security threats. A notable example cited is a 2024 cyberattack on the acquired Change Healthcare business, which involved protected health information and personally identifiable information.
*   **AI and Evolving Threats:** Techniques for cyberattacks are becoming more sophisticated, partly due to the use of evolving AI technologies (including generative AI). The company faces risks related to unauthorized access, ransomware, malware, and insider threats.
*   **Third-Party Risks:** The company relies on third-party vendors for data processing, which introduces risks outside of direct oversight.
*   **Regulatory Landscape:** Rapidly evolving laws and regulations regarding health data and AI may alter the competitive landscape and impose new compliance requirements.

**Operational Dependencies**
*   **Provider Relationships:** Failure to maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers could materially and adversely affect the business.
*   **Technology Investment:** Keeping pace with fast-evolving AI technologies and information processing trends requires significant ongoing development and operational resources. Failure to anticipate future technology developments or manage the costs of technological changes could result in reputational harm and adverse business effects.

RAG — RISK FACTORS:
[From Pinecone cache] The primary risk factors disclosed include:

*   **Inaccurate Cost Estimation and Management:** Failure to accurately predict, price, or manage medical costs and administrative expenses for risk-based products could materially and adversely affect financial results. This includes risks related to Optum Health’s fully accountable value-based care arrangements, where an inability to provide higher-quality outcomes at lower costs or integrate care delivery models could impact operations.
*   **Data Integrity and Information Systems:** Failure to maintain the integrity, availability, or security of data, or to successfully consolidate, integrate, upgrade, or expand information systems, could harm the business. This includes risks associated with inaccurate data, failures in health or IT products, difficulty in pricing, fraud detection issues, and regulatory sanctions.
*   **Technology and AI Challenges:** Risks related to the rapid evolution of technology, including artificial intelligence (AI) and generative AI. These include the potential for software defects, complications in installation or integration, failure to keep pace with technological changes, and the high costs associated with maintaining and developing new systems.
*   **Cybersecurity and Data Privacy:** Exposure to cyberattacks, privacy breaches, and data security incidents involving protected personal information or proprietary data. This includes risks from third-party vendors, sophisticated hacking techniques, ransomware, and the potential for operational disruptions, financial liability, and reputational harm. A specific example cited is a 2024 cyberattack on the Change Healthcare business.
*   **Regulatory and Legal Compliance:** Uncertain and evolving laws and regulations related to health data and information technologies, both domestically and internationally, which may alter the competitive landscape or impose new compliance requirements.
*   **Relationship Management:** Failure to develop and maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group trades at $378.58 with a market capitalization of approximately $340 billion, reflecting its dominant position in the healthcare sector. The company reports trailing revenue of $450.5 billion and a net income of $14.1 billion, resulting in a profit margin of 3.14%. Its current P/E ratio stands at 24.35, which is notably higher than the forward P/E of 16.74, suggesting expected earnings growth. This valuation gap indicates that the market anticipates improved profitability or multiple expansion in the near term. Overall, the financial profile demonstrates strong top-line scale with a reasonable trajectory for margin improvement.

### Recent Developments

UnitedHealth Group filed its 2026 Annual Report on Form 10-K on March 2, 2026, reaffirming standard forward-looking statement protections without introducing new material risk factors. The company subsequently submitted its Second Quarter 2026 10-Q on August 10, 2026, confirming that no significant changes have occurred to the risk profile outlined in the previous year's annual filing. Additionally, the Q10-Q disclosure indicates ongoing share repurchase activities, signaling continued commitment to returning capital to shareholders. Investors should monitor these filings for any emerging regulatory or operational shifts, as the company maintains that existing risks remain the primary focus for future performance.

### SEC Filing Highlights
Nearly 80% of UnitedHealth Group’s consolidated revenues derive from risk-based products, making profitability highly sensitive to the accuracy of medical cost estimates and the ability to manage inflation, utilization, and regulatory changes. The company faces significant operational risks from its reliance on data integrity and complex system integrations, where inaccuracies or failures can lead to pricing errors, fraud, and increased operating expenses. Cybersecurity remains a critical concern, particularly following the 2024 Change Healthcare breach, as sophisticated threats involving generative AI and third-party vendor vulnerabilities continue to evolve. Additionally, maintaining competitive advantage requires substantial ongoing investment in technology and AI capabilities, while failure to sustain strong relationships with healthcare providers could materially adversely affect business performance.

### Risk Factors

*   **Cybersecurity and Data Privacy:** Exposure to sophisticated cyberattacks, ransomware, and data breaches involving protected personal information, which can lead to significant operational disruptions, financial liability, and reputational harm, as evidenced by the 2024 Change Healthcare incident.
*   **Inaccurate Cost Estimation and Management:** Failure to accurately predict, price, or manage medical costs and administrative expenses for risk-based products, particularly within Optum Health’s value-based care arrangements, could materially adversely affect financial results.
*   **Technology and AI Challenges:** Risks associated with the rapid evolution of technology, including artificial intelligence, such as software defects, integration complications, and the high costs of maintaining and developing new systems to keep pace with industry changes.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group stands as a dominant force in the healthcare sector, leveraging a $450.5 billion revenue base and a $340 billion market capitalization to maintain its industry leadership. The stock is currently notable for its valuation dynamics, where a trailing P/E of 24.35 contrasts with a forward P/E of 16.74, signaling market expectations for near-term earnings growth and margin expansion. The single most important near-term variable shaping the investment outcome is the company’s ability to accurately manage medical cost estimates and mitigate cybersecurity risks following the 2024 Change Healthcare breach.

### Outlook
The directional outlook for UnitedHealth Group is cautiously constructive, supported by strong top-line scale and expected earnings growth implied by the valuation gap between trailing and forward multiples. Key variables to monitor include the accuracy of medical cost estimates for its risk-based products, the efficacy of cybersecurity defenses post-Change Healthcare, and the successful integration of AI capabilities to maintain competitive advantage. The thesis would be strengthened by sustained margin improvement and stable provider relationships, while it would be weakened by significant operational disruptions, pricing errors due to data integrity failures, or an inability to manage inflation and utilization trends effectively.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically audit every quantitative, forward-looking, and specific factual claim in the Executive Summary and Outlook sections.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "a $450.5 billion revenue base"
LABEL: SUPPORTED
REASON: The source data lists revenue of $450,525,986,816, which rounds to $450.5 billion, and the Financial Health pre-written section states "trailing revenue of $450.5 billion."

---

CLAIM: "a $340 billion market capitalization"
LABEL: SUPPORTED
REASON: The source data lists market_cap of $339,811,434,496, which rounds to approximately $340 billion, consistent with the Financial Health section's "approximately $340 billion."

---

CLAIM: "a trailing P/E of 24.35"
LABEL: SUPPORTED
REASON: The source data lists pe_ratio of 24.34598, which rounds to 24.35; the Financial Health section also states "24.35."

---

CLAIM: "a forward P/E of 16.74"
LABEL: SUPPORTED
REASON: The source data lists forward_pe of 16.743778, which rounds to 16.74, consistent with the Financial Health section's "16.74."

---

CLAIM: "signaling market expectations for near-term earnings growth and margin expansion"
LABEL: INFERENCE
REASON: The directional conclusion that a trailing P/E (24.35) materially exceeding the forward P/E (16.74) signals expected earnings growth is a standard, directly derivable interpretation stated explicitly in the Financial Health section ("suggesting expected earnings growth").

---

CLAIM: "the 2024 Change Healthcare breach"
LABEL: SUPPORTED
REASON: The RAG SEC Highlights and Risk Factors sections explicitly cite "a 2024 cyberattack on the acquired Change Healthcare business."

---

**OUTLOOK**

---

CLAIM: "expected earnings growth implied by the valuation gap between trailing and forward multiples"
LABEL: INFERENCE
REASON: The gap between trailing P/E of 24.35 and forward P/E of 16.74 is present in the source data, and the directional inference of expected earnings growth is explicitly stated in the Financial Health pre-written section.

---

CLAIM: "risk-based products" (as the category subject to medical cost estimate accuracy)
LABEL: SUPPORTED
REASON: The SEC Filing Highlights and RAG sections explicitly state that nearly 80% of revenues derive from "risk-based products" and that profitability is sensitive to medical cost estimates for those products.

---

CLAIM: "nearly 80% of consolidated revenues derive from risk-based products" (implied context for the medical cost variable)
LABEL: SUPPORTED
REASON: The RAG SEC Highlights explicitly state "Nearly 80% of total consolidated revenues come from risk-based products," and this figure is repeated in the SEC Filing Highlights pre-written section. *(Note: this figure appears in the Outlook's implied context rather than as an explicit quoted claim in the Outlook text itself, but it underpins the risk-based products reference — no separate explicit percentage claim is made in the Outlook text.)*

---

CLAIM: "the efficacy of cybersecurity defenses post-Change Healthcare"
LABEL: SUPPORTED
REASON: The 2024 Change Healthcare cyberattack is explicitly documented in the RAG and Risk Factors sections as an ongoing cybersecurity concern.

---

CLAIM: "the successful integration of AI capabilities to maintain competitive advantage"
LABEL: SUPPORTED
REASON: The RAG SEC Highlights and Risk Factors sections explicitly identify AI and technology integration as a key risk and competitive requirement ("Keeping pace with fast-evolving AI technologies… requires significant ongoing development").

---

CLAIM: "sustained margin improvement"
LABEL: INFERENCE
REASON: The Financial Health section states "a reasonable trajectory for margin improvement," making this a direct restatement of a conclusion drawn from the source data (3.14% profit margin with a forward P/E implying earnings growth).

---

CLAIM: "stable provider relationships"
LABEL: SUPPORTED
REASON: The Risk Factors and RAG sections explicitly identify "failure to develop and maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers" as a named material risk.

---

CLAIM: "pricing errors due to data integrity failures"
LABEL: SUPPORTED
REASON: The RAG SEC Highlights explicitly state "Inaccurate, incomplete, or outdated data can lead to… pricing errors," and this is echoed in the SEC Filing Highlights pre-written section.

---

CLAIM: "an inability to manage inflation and utilization trends effectively"
LABEL: SUPPORTED
REASON: The RAG SEC Highlights explicitly list "medical inflation, increased service utilization" as cost drivers that can cause actual costs to exceed estimates.

---

**SUMMARY TABLE**

| # | Claim | Label |
|---|-------|-------|
| 1 | $450.5 billion revenue base | SUPPORTED |
| 2 | $340 billion market capitalization | SUPPORTED |
| 3 | Trailing P/E of 24.35 | SUPPORTED |
| 4 | Forward P/E of 16.74 | SUPPORTED |
| 5 | Near-term earnings growth and margin expansion signal | INFERENCE |
| 6 | 2024 Change Healthcare breach | SUPPORTED |
| 7 | Earnings growth implied by valuation gap | INFERENCE |
| 8 | Risk-based products as medical cost variable | SUPPORTED |
| 9 | Post-Change Healthcare cybersecurity efficacy | SUPPORTED |
| 10 | AI integration for competitive advantage | SUPPORTED |
| 11 | Sustained margin improvement | INFERENCE |
| 12 | Stable provider relationships | SUPPORTED |
| 13 | Pricing errors due to data integrity failures | SUPPORTED |
| 14 | Inflation and utilization management | SUPPORTED |

**No claims were found to be UNSUPPORTED.** All quantitative figures check out arithmetically against the raw source data, period labels are consistent, and no entity or figure was identified that is absent from the source context.
